Replies to post #5909 on AVANIR PHARMACEUTICALS (AVNR)

[Prudent Capitalist]

I agree all the news is great, and we just had that great surge up to $5.00 on very high volume. Hard to figure, but still several reputable firms with price3 targets in the $7 - $15 range on AVNR. One thing that would help is a positive ruling on the last 2 patent cases. The major pharma's all settled and agreed to hold off on the generic for Nuedexta until August of 2026. That decision would appear to bode well for AVNR with the 2 smaller more obscure pharma's that5 went to trial on the issue. Decision should come any day now.